These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 25308796)

  • 21. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
    J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Shudo A; Kishimoto H; Takaoka K; Noguchi K
    Osteoporos Int; 2018 Oct; 29(10):2315-2321. PubMed ID: 29967931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database.
    Amigues C; Fresse A; Roux CH; Gauthier S; Vieillard MH; Drici MD; Breuil V;
    Joint Bone Spine; 2023 Dec; 90(6):105599. PubMed ID: 37271278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.
    Song M; Alshaikh A; Kim T; Kim S; Dang M; Mehrazarin S; Shin KH; Kang M; Park NH; Kim RH
    J Endod; 2016 Nov; 42(11):1641-1646. PubMed ID: 27637460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: two cases and review of the literature.
    Katz J; Ordoveza PA
    Quintessence Int; 2014 Sep; 45(8):685-90. PubMed ID: 25019116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution of oral bisphosphonate and steroid-related osteonecrosis of the jaw--a serial case analysis.
    Chiu CT; Chiang WF; Chuang CY; Chang SW
    J Oral Maxillofac Surg; 2010 May; 68(5):1055-63. PubMed ID: 20403529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
    Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
    Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.
    Watters AL; Hansen HJ; Williams T; Chou JF; Riedel E; Halpern J; Tunick S; Bohle G; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):192-200. PubMed ID: 23036797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction.
    Bodem JP; Kargus S; Eckstein S; Saure D; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 May; 43(4):510-4. PubMed ID: 25841311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
    Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
    J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
    Ishikawa T
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats.
    Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M
    J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonate-related osteonecrosis of the jaws--a case report.
    Kamoh AK; Ogle O
    Compend Contin Educ Dent; 2012 May; 33(5):e74-7. PubMed ID: 23268588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw.
    Koerdt S; Dax S; Grimaldi H; Ristow O; Kuebler AC; Reuther T
    J Oral Pathol Med; 2014 Jul; 43(6):448-53. PubMed ID: 24456519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
    Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
    Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.